SCHEMBL13115462

SCHEMBL13115462

CCC(C[N+]1([N-]C(=O)c2ccc(OC)cc2OC)CCCCC1)OC(=O)Nc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ MEN1 O00255 6/20 0.40
▸ KMT2A Q03164 6/20 0.40
▸ MAPT P10636 2/20 0.40
▸ NPC1 O15118 3/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ KLK7 P49862 1/20 0.38
▸ LMNA P02545 2/20 0.37
▸ TP53 P04637 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.37
▸ AHR P35869 1/20 0.37
▸ GAA P10253 2/20 0.36
▸ HTT P42858 2/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ DRD4 P21917 1/20 0.36
▸ SLC6A2 P23975 1/20 0.36
▸ CCKAR P32238 1/20 0.36
▸ OPRM1 P35372 1/20 0.36
▸ DRD3 P35462 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13115470 0.90 MAPT (0.43) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL13115468 0.87 LMNA (0.43) L3MBTL1MEN1KMT2AMAPTNPC1
SCHEMBL13135884 0.83 MEN1 (0.42) L3MBTL1TDP1MEN1KMT2AMAPT
SCHEMBL13115460 0.81 MAPT (0.42) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL13115558 0.79 TP53 (0.40) L3MBTL1TDP1MEN1KMT2ANPC1
SCHEMBL13115459 0.78 TDP1 (0.44) L3MBTL1TDP1MEN1KMT2AMAPT
SCHEMBL13115474 0.77 ATM (0.36) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL13115472 0.77 PABPC1 (0.38) L3MBTL1MEN1KMT2AMAPTNPC1
SCHEMBL13115478 0.76 NPC1 (0.39) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL13115467 0.74 ELANE (0.33) L3MBTL1MEN1KMT2AMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8466238-B2 Latent curing agents, epoxy resin compositions containing the same, sealing materials, and organic EL displays MITSUI CHEMICALS, INC. (JP) 2013-06-18 — — US disclosed
US-8466238-B2 Latent curing agents, epoxy resin compositions containing the same, sealing materials, and organic EL displays MITSUI CHEMICALS, INC. (JP) 2013-06-18 — — US disclosed
US-20100253213-A1 LATENT CURING AGENTS, EPOXY RESIN COMPOSITIONS CONTAINING THE SAME, SEALING MATERIALS, AND ORGANIC EL DISPLAYS MITSUI CHEMICALS, INC (JP) 2010-10-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100253213-A1 LATENT CURING AGENTS, EPOXY RESIN COMPOSITIONS CONTAINING THE SAME, SEALING MATERIALS, AND ORGANIC EL DISPLAYS LTA4H, EPHX2, EPHX1 L3MBTL1 386/4885TDP1 2396/4885MEN1 3875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback